In MMXXII Medical Technology Orbis Terrarum Summit, tenuit in December XIV - XV ad Suzhou Leo Hill Internationalis Conference Center, erat communi organized by VB100, VcBeat, Crusta Research Institute et Suzhou High - Tech Zonam Management Committee. Et summum focused in convergence de technology et curis, ferentes industriam, academia, investigationis, et investment ad promovere innovation et progressionem in medical technology sector. A Highlight de culmine erat vb - invenies award presentation.
Hebgene Biopharma invitavit ad adtende VB - Award Ceremony, ubi eius cellula et gene Therapy CDMM comprehensive solutio est agnita in MMXXII "in genus optimus biotechnology productum (solution).
Hoc award, presented per VCBeat scriptor VB100 et Crusta Research Institute, erat aperta ad curis ad societates trans variis domains et incrementum gradus. EVALUATED maxime amet medicinae technology products (solutions) intra tria major technology clusters: biotechnology, dolor vestibulum et novum materiae technology, et digital et notitia technology. Iudicat panel ex industria consociati peritos, seasoned investors, testa investigationes Institutum investigatores, et curis industria instrumentis personas, usus et ustulo in annui perficientur Moderalis Ponde Ponder et Driving Suspendisse, Innovation Iteration, et Interactive Communication.
Hoc recognition Reaffirms Hebgene Bioffharma scriptor Innovative "Quality - sitas" CQDMO Service System et Validates eius praestantes ministerium capabilities. Sicut particeps in semita of industriae cellula therapy medicamentis, Hebgene Biopharma dedicavit ad meliorem efficientiam de cellula therapy medicamento industrialem a fonte. Illi autem independently developed a serie cellula Therapy - Related Technology Platform systems cum finis est de core ludio ludius in Sina scriptor futurum cellula therapy medicamentis curatio CDMO, providing cellula Lorem medicinae ad industriarum in cellula therapy in medicamentis ad elit.
Post tempus: MMXII - XII - XIX 00:00:00
